Restrictions could hurt sales with the passage of the CHIPS and Science Act last year.
Also, Arm looking to Intel as possible anchor investor in IPO bid.
Leading indicators out of sync with S&P data.
Don’t expect a turnaround until Q1’24.
And the evolution that got us where we are today.